This is an aggregated industry headline. Read the full story at Drug Channels →
The 340B Contract Pharmacy Market in 2026: A Maturing Industry Dominated by Big Chains and PBMs
By Adam J. Fein, Ph.D. and Greis Kapexhiu It's time for Drug Channels Institute's latest exclusive analysis of the 340B contract pharmacy market, which continues to boom along with the overall program's expansion.However, our 2026 analysis finds that the contract pharmacy market is now entering a mo
By Drug Channels
· Jun 2, 2026
· via Drug Channels
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Held just after the prestigious Cannes Film Festival in southern France, the Cannes Lions Festival of Creativi…
The WeekFierceBiotech ↗
Biogen isn't wasting any time integrating its multibillion-dollar purchase of Apellis, revealing plans to part…
The WeekBriefing
STAT reports that new technical advances in embryo genome editing are again stirring public and policy debate …